1-20 of 38
Jia Liu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Prospective, Multi-Center, Randomized, Controlled Clinical Trial to Explore the Role of Mesenchymal Stem Cells in Preventing Graft Versus Host Disease

Han Yao, Xiaoqi Wang, Ruihao Huang, Haixia Fu, Ren Lin, Yimei Feng, Xiaojuan Deng, Ting Chen, Lidan Zhu, Jia Liu, Yuqing Liu, Lu Zhao, Lu Wang, Cheng Zhang, Peiyan Kong, Li Gao, Lei Gao, Qifa Liu, Xiaohui Zhang, Xi Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 3556.
https://doi.org/10.1182/blood-2023-189104
Published: 2023
Journal Articles

Efficacy Analysis of Ixazomib-Based Regimens Based on Dynamic Frailty Assessment in Elderly and Frail Patients with Newly Diagnosed Multiple Myeloma

Jianmei Xu, Hua Xue, Songying Zhao, Jing Wang, Huimei Guo, Jiangbo Zhang, Jia Liu, Luoming Hua, Mingjie Tian, Mingfeng Zhao
Journal: Blood
Blood (2023) 142 (Supplement 1): 6690.
https://doi.org/10.1182/blood-2023-185230
Published: 2023
Journal Articles

Application Gene Variation Detection before and after Hematopoietic Stem Cell Transplantation to Predict the Relapse of Hematopoietic Neoplasm Patients after Transplantation: Retrospective Data from a Single Center in China

Jia Liu, Peiyan Kong, Lidan Zhu, Shichun Gao, Lu Wang, Huanfeng Liu, Ting Chen, Yimei Feng, Yuqing Liu, Lei Gao, Xi Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6975.
https://doi.org/10.1182/blood-2023-188458
Published: 2023
Journal Articles

Targeting RBM39-MEK5 Axis Synergizes with Bortezomib to Inhibit Multiple Myeloma Malignancy

Jia Liu, Zilu Zhang, Wenbin Xu, Ming-Yuan Jia, Chengyu Wu, Yan Hua
Journal: Blood
Blood (2023) 142 (Supplement 1): 4674.
https://doi.org/10.1182/blood-2023-182900
Published: 2023
Journal Articles

The Application of Gait Speed and Grip Strength As a Frailty Screening Tool in Elderly Patients with Mulitiple Myeloma

Jiangbo Zhang, Hua Xue, Rong Fu, Jing Wang, Songying Zhao, Huimei Guo, Jia Liu, Jianmei Xu, Yao Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 3371.
https://doi.org/10.1182/blood-2023-188179
Published: 2023
Journal Articles

Efficacy and Safety of Hetrombopag in Promoting Platelet Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective, Multicenter, Randomized Controlled Clinical Trial

Yimei Feng, Linhui Wang, Tao Lang, Mingqiang Ren, Hai Yi, Jianchuan Deng, Liangliang Ma, Hongyun Xing, Dan Wang, Han Yao, Ting Chen, Yuqing Liu, Lidan Zhu, Jia Liu, Shichun Gao, Lei Gao, Xi Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 3539.
https://doi.org/10.1182/blood-2023-188481
Published: 2023
Journal Articles

Efficacy and Safety of Herombopag for the Treatment of Secondary Failure of Platelet Recovery after Allogeneic Hematopoietic Stem Cell Transplantation: The Single Center Prospective Study from China

Huanfeng Liu, Lidan Zhu, Jia Liu, Shichun Gao, Lu Wang, Peiyan Kong, Ting Chen, Yimei Feng, Yuqing Liu, Lei Gao, Xi Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6967.
https://doi.org/10.1182/blood-2023-188407
Published: 2023
Journal Articles

Retrospective Analysis of Clinical Outcomes of Utilizing R-CHOP Plus Zanubrutinib for High-Risk Diffuse Large B Cell Lymphoma Patients with Extranodal Involvement or MYC/BCL2 Double Expression

Wanbin Fu, Jia Liu, Dan Xiao, Huanbin Zhao, Ting Wang, Jiong Hu, Jian Hou, Hua Zhong, Lan Xu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6323.
https://doi.org/10.1182/blood-2023-182704
Published: 2023
Journal Articles

CD19/BCMA Dual-Targeting Fastcar-T GC012F for Patients with Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma: An Update

Xinfeng Chen, Yu Ping, Ling Li, Lei Zhang, Xudong Zhang, Jianmin Huang, Jia Liu, Gui Li, Huan Shi, Jiaping He, Yi Liang, Lihong Weng, Wenjie Yin, Lianjun Shen, Wei William Cao, Wenling Li, Mingzhi Zhang, Yi Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6847.
https://doi.org/10.1182/blood-2023-185476
Published: 2023
Journal Articles

Updated Results of a Phase I Open-Label Single-Arm Study of Dual Targeting BCMA and CD19 Fastcar-T Cells (GC012F) As First-Line Therapy for Transplant-Eligible Newly Diagnosed High-Risk Multiple Myeloma

Juan Du, Wanting Qiang, Jing Lu, Yanchun Jia, Haiyan He, Jin Liu, Pei Guo, Ying Yang, Zhongyuan Feng, Lina Jin, Xiaoqiang Fan, Jia Liu, Qi Zhang, Lianjun Shen, Lihong Weng, Wenling Li, Wei Cao
Journal: Blood
Blood (2023) 142 (Supplement 1): 1022.
https://doi.org/10.1182/blood-2023-174841
Published: 2023
Journal Articles

IRF4-BLOC1S5, the First Genomic Fusion Gene Identified in the TEMPI Syndrome

Jia Liu, Zilu Zhang, Wenbin Xu, Qing Yu, Ming-Yuan Jia, Yan Hua
Journal: Blood
Blood (2023) 142 (Supplement 1): 1923.
https://doi.org/10.1182/blood-2023-184488
Published: 2023
Journal Articles

Evaluating the Effectiveness of Risk Adjustment Using Dynamic Frailty Assessment in Treating Newly Diagnosed Multiple Myeloma in Elderly Patients

Jianmei Xu, Hua Xue, Songying Zhao, Jing Wang, Huimei Guo, Jiangbo Zhang, Jia Liu, Mingjie Tian, Luoming Hua, Mingfeng Zhao
Journal: Blood
Blood (2023) 142 (Supplement 1): 6644.
https://doi.org/10.1182/blood-2023-185684
Published: 2023
Journal Articles

Discovery of novel predisposing coding and noncoding variants in familial Hodgkin lymphoma

Jamie E. Flerlage, Jason R. Myers, Jamie L. Maciaszek, Ninad Oak, Sara R. Rashkin, Yawei Hui, Yong-Dong Wang, Wenan Chen, Gang Wu, Ti-Cheng Chang, Kayla Hamilton, Saima S. Tithi, Lynn R. Goldin, Melissa Rotunno, Neil Caporaso, Aurélie Vogt, Deborah Flamish, Kathleen Wyatt, Jia Liu, Margaret Tucker, Christopher N. Hahn, Anna L. Brown, Hamish S. Scott, Charles Mullighan, Kim E. Nichols, Monika L. Metzger, Mary L. McMaster, Jun J. Yang, Evadnie Rampersaud
Journal: Blood
Blood (2023) 141 (11): 1293–1307.
https://doi.org/10.1182/blood.2022016056
Published: 2023
Includes: Supplemental data
Journal Articles

Interpreting Immune Reconstitution and Clinical Outcome By Single-Cell Transcriptomic Analysis in T-ALL Patients Undergoing Donor-Derived CD7 CAR-T Immunotherapy

Hui Shi, Kai Hu, Fan Yang, Zhuojun Liu, Jia Liu, Wei Chen, Jian Yu
Journal: Blood
Blood (2022) 140 (Supplement 1): 10422–10423.
https://doi.org/10.1182/blood-2022-165035
Published: 2022
Journal Articles

Phase I Open-Label Single-Arm Study of BCMA/CD19 Dual-Targeting FasTCAR-T Cells (GC012F) As First-Line Therapy for Transplant-Eligible Newly Diagnosed High-Risk Multiple Myeloma

Juan Du, Weijun Fu, Jing Lu, Wanting Qiang, Haiyan He, Jin Liu, Ying Yang, Zhongyuan Feng, Lina Jin, Xiaoqiang Fan, Jia Liu, Qi Zhang, Lianjun Shen, Lihong Weng, Wei Cao
Journal: Blood
Blood (2022) 140 (Supplement 1): 889–890.
https://doi.org/10.1182/blood-2022-162295
Published: 2022
Journal Articles

Efficiency and Toxicity of Imatinib Mesylate Combined with Atorvastatin Calcium for Steroid-Refractory Chronic Graft-Versus-Host Disease

Ting Chen, Han Yao, Yuqing Liu, Lidan Zhu, Jia Liu, Liu Huanfeng, Shichun Gao, Lu Wang, Lu Zhao, Yimei Feng, Lei Gao, Xi Zhang, Peiyan Kong
Journal: Blood
Blood (2022) 140 (Supplement 1): 4784–4785.
https://doi.org/10.1182/blood-2022-169673
Published: 2022
Journal Articles

Human Leukocyte Antigen Contributes to Childhood Endemic Burkitt Lymphoma in Eastern Africa: A Case-Control Association Study

Zhiwei Liu, Yang Luo, Samuel Kirimunda, Murielle Verboom, Olusegun O Onabajo, Mateus H Gouveia, Martin Ogwang, Patrick Kerchan, Steven Reynolds, Constance N Tenge, Pamela A Were, Robert T Kuremu, Walter N Wekesa, Nestory Masalu, Esther Kawira, Tobias Kinyera, Isaac Otim, Ismail D Legason, Hadijah Nabalende, Herry Dhudha, Leona W Ayers, Robert J Biggar, Kishor G. Bhatia, James J Goedert, Nathan Cole, Wen Luo, Jia Liu, Michelle Manning, Belynda Hicks, Ludmila Prokunina-Olsson, George Chagaluka, Tom Johnston, Nora Mutalima, Eric Borgstein, George N Liomba, Steve Kamiza, Nyengo Mkandawire, Collins Mitambo, Elizabeth Molyneux, Robert Newton, Ann W Hsing, James E Mensah, Ruth M Pfeiffer, Amy Hutchinson, Carrington Mary, Meredith Yeager, Moses Joloba, Rainer Blasczyk, Stephen J. Chanock, Soumya Raychaudhuri, Sam M. Mbulaiteye
Journal: Blood
Blood (2022) 140 (Supplement 1): 9233–9235.
https://doi.org/10.1182/blood-2022-169911
Published: 2022
Journal Articles

Decitabine Combined with FB3 As Conditional Regimen for Elderly/Weak Acute Myeloid Leukemia Patient with Allo-HSCT

Shichun Gao, Peiyan Kong, Lidan Zhu, Jia Liu, Liu Huanfeng, Lu Wang, Cheng Zhang, Li Gao, Lei Gao, Xi Zhang
Journal: Blood
Blood (2022) 140 (Supplement 1): 12835–12836.
https://doi.org/10.1182/blood-2022-169384
Published: 2022
Journal Articles

Germline-Somatic Interactions in Myelofibrosis Susceptibility

Derek W Brown, Youjin Wang, Andrew St. Martin, Stephen R. Spellman, Shu-Hong Lin, Olivia Lee, Alyssa Klein, Tongwu Zhang, Weiyin Zhou, Kristine Jones, Amy Hutchinson, Jia Liu, Bin Zhu, Casey Dagnall, Sairah Khan, Maryam Rafati, Tao Wang, H. Joachim Deeg, Vikas Gupta, Stephanie J. Lee, Meredith Yeager, Sharon A. Savage, Wael Saber, Shahinaz Gadalla, Mitchell Machiela
Journal: Blood
Blood (2021) 138 (Supplement 1): 313.
https://doi.org/10.1182/blood-2021-150634
Published: 2021
Journal Articles

G-CSF Upregulates the Expression of Aquaporin-9 through C/EBP-Beta to Enhance the Cytotoxic Activity of Arsenic Trioxide to Acute Myeloid Leukemia Cells

Wanbin Fu, Lan Xu, Jia Liu, Xiaofeng Han, Junying Wang, Xinpeng Wang, Huanbin Zhao, Jian Hou, Jiong Hu, Hua Zhong
Journal: Blood
Blood (2021) 138 (Supplement 1): 4338.
https://doi.org/10.1182/blood-2021-149973
Published: 2021